Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision history shows addition of Revision: v3.4.2 and deletion of Revision: v3.4.1. This is a minor update with no changes to core content or user-facing information; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content changes detected.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded a glossary display and updated several metadata labels, including capitalization of 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision from v3.3.4 to v3.4.0. These are UI and metadata adjustments that do not alter the study content or functionality.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.